Lixte Biotechnology Inc. (LIXT)
2.49
0.06 (2.47%)
At close: Jan 14, 2025, 3:58 PM
2.42
-2.81%
After-hours Jan 14, 2025, 04:28 PM EST
undefined% (undefined)
| Bid | 2.07 |
| Market Cap | 5.60M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -1.73 |
| PE Ratio (ttm) | -1.44 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 2.55 |
| Volume | 7,733 |
| Avg. Volume (20D) | 602,801 |
| Open | 2.45 |
| Previous Close | 2.43 |
| Day's Range | 2.41 - 2.50 |
| 52-Week Range | 1.31 - 4.40 |
| Beta | undefined |
About LIXT
Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers; and encompasses two major categories of compounds at var...
Industry Biotechnology
Sector Healthcare
IPO Date Oct 25, 2007
Employees 3
Stock Exchange NASDAQ
Ticker Symbol LIXT
Website https://lixte.com
9 months ago ·
Source
+55.75%
LIXTE shares are trading higher after the company ...
Unlock content with
Pro Subscription
